Related Experiment Video
Updated: Jun 5, 2026

Assessing Endothelial Vasodilator Function with the Endo-PAT 2000
Published on: October 15, 2010
Early hypercholesterolemia contributes to vasomotor dysfunction and injury associated atherogenesis that can be
Kathleen G Raman1, Robin E Gandley, Jennifer Rohland
1Division of Vascular Surgery, Department of Surgery, University of Pittsburgh, Pittsburgh, Pa 15213, USA.
Insights
Early hypercholesterolemia impairs blood vessel function and contributes to vascular injury. Nitric oxide (NO) therapy, specifically via iNOS gene transfer, effectively inhibits atheroma formation, suggesting potential therapeutic roles.
Area of Science:
- Cardiovascular Biology
- Vascular Medicine
- Atherosclerosis Research
Background:
- Atherosclerosis impairs nitric oxide (NO)-dependent vasodilation, contributing to vasomotor dysfunction.
- The role of early hypercholesterolemia, prior to significant vascular changes, in vasomotor dysfunction and vascular injury remains unclear.
Purpose of the Study:
- To investigate if early hypercholesterolemia induces vasomotor dysfunction and vascular injury.
- To assess the efficacy of NO therapy in protecting against vascular injury in hypercholesterolemic settings.
Main Methods:
- Oxidized low-density lipoprotein (oxLDL) and inducible NO synthase (iNOS) gene transfer effects on smooth muscle cell proliferation were measured.
- Vasomotor function of carotid arteries from hypercholesterolemic (ApoE KO) and wild-type mice on different diets was assessed using an arteriograph system, before and after injury.
- The impact of iNOS gene transfer on vascular remodeling and function post-injury was examined.
Main Results:
- OxLDL increased smooth muscle cell proliferation; iNOS expression inhibited this effect, even with oxLDL present.
- Hypercholesterolemia reduced endothelium-dependent vasodilation in uninjured arteries, with effects worsening with duration.
- Vascular injury severely disrupted vasodilation, but recovery was observed by 4 weeks; ApoE KO mice developed atheromatous lesions post-injury, unlike controls.
Conclusions:
- Early hypercholesterolemia impairs endothelial function, dependent on duration and severity.
- Vascular injury in hypercholesterolemia promotes atherogenesis, involving distinct mechanisms from endothelial dysfunction.
- iNOS gene transfer effectively inhibited atheroma formation, supporting early hypercholesterolemia management and NO-based therapies.
Objective:
Atherosclerosis results in vasomotor dysfunction, in part, through impairment of nitric oxide (NO) dependent vasodilation. It is unclear whether blood vessels are dysfunctional in an early environment of hypercholesterolemia alone and if this contributes to the vascular injury response. We hypothesize that early hypercholesterolemia, prior to gross vascular changes, contributes to vasomotor dysfunction and the vascular injury response. The efficacy of NO therapy to protect against the injury response in this setting was also assessed.
Methods:
The effect of oxidized low density lipoprotein (oxLDL) and inducible NO synthase (iNOS) gene transfer on rat aortic smooth muscle cell (SMC) proliferation was measured with (3)H-thymidine incorporation. Common carotid arteries (CCA) from wild-type C57BL6 (WT or C57) and apolipoprotein E deficient (ApoE KO) mice fed normal or Western diets for 6 to 8 weeks were tested for vasomotor function using an arteriograph system. Studies were repeated after CCA injury. The effect of iNOS gene transfer on morphometry by histology and vasomotor responses in injured CCAs in ApoE KO was examined.
Results:
OxLDL increased SMC proliferation by >50%. In SMC expressing iNOS, NO production was unaffected by oxLDL and reduced oxLDL and still inhibited SMC proliferation. Endothelium dependent vasorelaxation was reduced in uninjured CCAs from ApoE KO and C57 mice on the Western vs normal diet (ApoE 39% ± 2% vs 55% ± 13%; C57 50% ± 13% vs 76% ± 5%, P < .001) and was increased with longer durations of hypercholesterolemia. Endothelium-dependent and independent vasodilator responses were severely disrupted in C57 and ApoE KO mice 2 weeks following CCA injury but both recovered by 4 weeks. CCA injury in ApoE KO mice resulted in the formation of atheromatous lesions while C57 mice showed no change (intima 27,795 ± 1829 vs 237 ± 28 microm(2); media 46,306 ± 2448 vs 11,714 ± 392 microm(2), respectively; P < .001). This structural change in the ApoE KO reduced distensibility and increased stiffness. Finally, iNOS gene transfer to injured CCA in ApoE KO mice dramatically reduced atheromatous neointimal lesion formation.
Conclusions:
Early hypercholesterolemia impairs endothelial function, with severity being related to duration and magnitude of hypercholesterolemia. Severe hypercholesterolemia leads to atheromatous lesion formation following injury and stresses the role of vascular injury in atherogenesis and suggests different mechanisms are involved in endothelial dysfunction and the injury response. Despite these changes, iNOS gene transfer still effectively inhibits atheroma formation. These findings support early correction of hypercholesterolemia and emphasize the potential role for NO based therapies in disease states.
Related Concept Videos
Nitric Oxide Signaling Pathway
Antihypertensive Drugs: Vasodilators
Coronary Artery Disease II: Pathophysiology
Antianginal Drugs: Nitrates and β-Blockers
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
Atherosclerosis III: Management
Hypertension II: Pathophysiology

